Last update 01 Nov 2024

OPKO IP Holdings II, Inc.

Private Company

Overview

Related

3
Drugs associated with OPKO IP Holdings II, Inc.
Calcifediol
Target
VDR
Mechanism
VDR agonists
Active Org.
Faes Farma SA [+2]
Originator Org.
Organon USA, Inc.
Active Indication
Hyperparathyroidism, Secondary [+1]
Inactive Indication
Bone Cancer [+10]
Drug Highest PhaseApproved
First Approval Ctry. / Loc.
US
First Approval Date05 Aug 1980
Ercalcitriol
Target
VDR
Mechanism
VDR agonists
Active Org.-
Originator Org.
OPKO Health, Inc.OPKO Health, Inc.
Active Indication-
Inactive Indication
Hyperparathyroidism, Secondary [+1]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
Lunacalcipol
Target
CYP24A1 x VDR
Mechanism
CYP24A1 inhibitors [+1]
Active Org.-
Originator Org.
OPKO Health, Inc.OPKO Health, Inc.
Active Indication-
Inactive Indication
Chronic Kidney Diseases [+4]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date-
5
Clinical Trials associated with OPKO IP Holdings II, Inc.
NCT01704079 / CompletedPhase 3
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Subjects With Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency
NCT01651000 / CompletedPhase 3
A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Efficacy and Safety of CTAP101 Capsules to Treat Secondary Hyperparathyroidism in Subjects With Stage 3 or 4 Chronic Kidney Disease and Vitamin D Insufficiency
NCT00888069 / CompletedPhase 1
A Randomized, Open-Label, Single-Dose Pilot Study of Oral and i.v. CTAP101 Evaluating PK and Safety in Stage 3 and 4 CKD Subjects With Vitamin D Insufficiency and SHPT
100 Clinical Results associated with OPKO IP Holdings II, Inc.
Login to view more data
0 Patents (Medical) associated with OPKO IP Holdings II, Inc.
Login to view more data
100 Deals associated with OPKO IP Holdings II, Inc.
Login to view more data
100 Translational Medicine associated with OPKO IP Holdings II, Inc.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 22 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Other
3
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Ercalcitriol
 ( VDR )		Kidney Failure, Chronic
More
Pending
Calcifediol
 ( VDR )		Kidney Failure, Chronic
More
Pending
Lunacalcipol
 ( CYP24A1 x VDR )		Kidney Failure, Chronic
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free